GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Autodesk, Inc. (ADSK) [hlAlert]

Rating:
Sell ADSK
up 3.34 %

Autodesk, Inc. (ADSK) downgraded to Sell by Citigroup

Posted on: Monday,  Mar 3, 2014  8:25 AM ET by Citigroup

Citigroup rated Sell Autodesk, Inc. (NASDAQ: ADSK) on 03/03/2014, when the stock price was $51.67. Since
then, Autodesk, Inc. has lost 3.23% as of 11/20/2015's recent price of $50.00.
If you would have followed this Citigroup's recommendation on ADSK, you would have gained 3.34% of your investment in 627 days.

Acadia Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. Their three clinical programs are ACP-103 for treatment-induced dysfunction in Parkinson?s disease, and ACP-104 and ACP-103, both for the treatment of schizophrenia.

Citi Investment Research is a highly respected research unit and is comprised of 390 research analysts across 22 countries. Citi Investment Research covers 3,100 companies, representing 90 percent of the market capitalization of the major global indices, and provides macro and quantitative analysis of global markets and sector trends. Combined with Citi's exceptional sales and trading capabilities and Smith Barney's financial consultants, the core focus of the group is to help investing clients make informed decisions by providing value-added, independent, insightful analysis.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/3/2014 8:25 AM Sell
None
51.67
as of 10/17/2014
1 Week up  5.45 %
1 Month up  7.46 %
3 Months up  8.35 %
1 YTD up  1.70 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/20/2007 9:25 AM Hold
None
45.60

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy